What is it about?
Skin cancers are the most common cancers in the world. We are developing a non-surgical strategy to treat skin cancers with an injectable that uses adhesive nanoparticle drug delivery in combination with immunotherapy.
Featured Image
Photo by National Cancer Institute on Unsplash
Why is it important?
If this strategy is successful, it has the potential to provide physicians with a way to treat some skin cancers without surgery, and not all patients are great candidates for surgery. This might also have implications for containing healthcare costs.
Perspectives
This was a true synergistic collaborative effort between laboratories in dermatology and biomedical engineering.
Michael Girardi
Yale University
Read the Original
This page is a summary of: Nonsurgical treatment of skin cancer with local delivery of bioadhesive nanoparticles, Proceedings of the National Academy of Sciences, February 2021, Proceedings of the National Academy of Sciences,
DOI: 10.1073/pnas.2020575118.
You can read the full text:
Contributors
The following have contributed to this page
